The largest prospective study, conducted by the Nordic Lymphoma Group (NGL-T-01), enrolled 115 patients with nodal PTCL (excluding ALK-positive ALCL), of whom 70% underwent auto-SCT. This evidence concerns the gene ALK and lymphoma.